We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cause of the Most Devastating Pandemics in History Revealed

By LabMedica International staff writers
Posted on 04 Feb 2014
Image: Tooth of one of the plague victims buried in Bavaria (Photo courtesy of McMaster University).
Image: Tooth of one of the plague victims buried in Bavaria (Photo courtesy of McMaster University).
A new study reveals that two of the world's most devastating pandemics, the plague of Justinian and the Black Death, were caused by distinct strains of the same pathogen.

Researchers at McMaster University (Hamilton, ON, Canada), Northern Arizona University (Flagstaff, USA), the University of Sydney (Australia), and other institutions isolated miniscule DNA fragments from the 1,500 year old teeth of two victims of the Justinian plague, who were buried in the Aschheim-Bajuwarenring cemetery (Bavaria, Germany); these are the oldest pathogen genomes obtained to date. Using these short fragments, the researchers reconstructed the genome of the bacterium responsible, and compared it to a database of genomes of more than a hundred contemporary strains.

The results showed that the bacterium was a strain of Yersinia pestis, the same pathogen responsible for the Black Death. But while the strain responsible for the Justinian outbreak was an evolutionary “dead-end” and faded out on its own, the other, likely a descendant of the Black Death strain, lead to another worldwide pandemic spreading from Hong Kong across the globe in the late 1800’s. According to the researchers, these findings suggest a new strain of plague could emerge again in humans in the future. The study was published online on January 28, 2014, in the Lancet Infectious Diseases.

“About 200 rodent species carry the plague and could potentially infect other animals or humans. Scientists need to sharpen their surveillance of plague in rodent populations to try averting future human infections,” said lead author Associate Professor Hendrik Poinar, PhD, director of the McMaster Ancient DNA Center. “If we happen to see a massive die-off of rodents somewhere, then it would become alarming. Plague is something that will continue to happen, but modern-day antibiotics should be able to stop it.”

The Plague of Justinian struck in the sixth century and it is estimated to have killed between 30 and 50 million people—virtually half the world's population—as it spread across Asia, North Africa, The Arabian peninsula, and Europe. The Black Death struck some 800 years later with similar force, killing 50 million Europeans in just four years (1347-1351).

Related Links:

McMaster University
Northern Arizona University
University of Sydney


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Automated Urinalysis Solution
UN-9000

Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more